RE: RE: RE: RE: RE: RE: Weekend TAI have heard that Alan Moore stated $6.00/share. Whether that comes true or not all depends on whether these treatments are successful or not.
So what does $6.00 tell us. Well at 150 mil shares, that's a market value of 900 million dollars.
To the average joe, that sounds like an incredible amount of money, but in the Pharm field, they deal in billions when it comes to drugs.
Some have put down the costs involved for many of the treatments SSS is addressing and those numbers reach multiple billions quite quickly.
What multiple does a company like SSS get? 15 times, 20?...
We were just shown an example of a nasdaq comparable company trading at a market cap of 144 million and they are only at phase 1
SSS is at phase 11b and is trading at around 54 million.
So what does that tell you?
In my opinion, again as a previous poster stated, the next announcement of full enrollment will kick us off for the next leg up. I forget the time frame, but isn't is around the end of this month?
Then as we get closer to some reports being due, the anticipation will grow and if there hasn't been any negative findings, the investment world will wake up to this play, which in my opinion, is when that rally from the .50's to the.80's will occur.
Throw in a Phizer partnership, and SSS will finally be appreciated, and we will be well rewarded for our patience.
In the scheme of things, not too much longer to wait now.
Happy Trading all
Mediascan